NM_000137.4:c.1027G>A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000137.4(FAH):c.1027G>A(p.Gly343Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G343E) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000137.4 missense
Scores
Clinical Significance
Conservation
Publications
- tyrosinemia type IInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, G2P, Orphanet, Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAH | NM_000137.4 | c.1027G>A | p.Gly343Arg | missense_variant | Exon 12 of 14 | ENST00000561421.6 | NP_000128.1 | |
FAH | NM_001374377.1 | c.1027G>A | p.Gly343Arg | missense_variant | Exon 13 of 15 | NP_001361306.1 | ||
FAH | NM_001374380.1 | c.1027G>A | p.Gly343Arg | missense_variant | Exon 13 of 15 | NP_001361309.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tyrosinemia type I Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Gly343 amino acid residue in FAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12203990, 21764616). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with tyrosinemia (PMID: 23927806). ClinVar contains an entry for this variant (Variation ID: 558592). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 343 of the FAH protein (p.Gly343Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at